Bank of America’s Apyx Medical APYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-17,687
| Closed | -$61.9K | – | 5756 |
|
|
2025
Q4 | $61.9K | Buy |
17,687
+35
| +0.2% | +$122 | ﹤0.01% | 5771 |
|
|
2025
Q3 | $37.8K | Sell |
17,652
-286
| -2% | -$605 | ﹤0.01% | 6919 |
|
|
2025
Q2 | $40.4K | Sell |
17,938
-3,912
| -18% | -$5.51K | ﹤0.01% | 6878 |
|
|
2025
Q1 | $29.9K | Hold |
21,850
| – | – | ﹤0.01% | 6866 |
|
|
2024
Q4 | $34.5K | Sell |
21,850
-231
| -1% | -$323 | ﹤0.01% | 6725 |
|
|
2024
Q3 | $27.4K | Buy |
22,081
+231
| +1% | +$292 | ﹤0.01% | 6682 |
|
|
2024
Q2 | $29.3K | Hold |
21,850
| – | – | ﹤0.01% | 6648 |
|
|
2024
Q1 | $29.7K | Hold |
21,850
| – | – | ﹤0.01% | 6668 |
|
|
2023
Q4 | $57.2K | Sell |
21,850
-8,344
| -28% | -$20.2K | ﹤0.01% | 6557 |
|
|
2023
Q3 | $96.6K | Buy |
30,194
+27,594
| +1,061% | +$129K | ﹤0.01% | 6265 |
|
|
2023
Q2 | $13.1K | Sell |
2,600
-2,000
| -43% | -$10.1K | ﹤0.01% | 6802 |
|
|
2023
Q1 | $13.2K | Sell |
4,600
-34
| -0.7% | -$99 | ﹤0.01% | 6862 |
|
|
2022
Q4 | $10.8K | Buy |
4,634
+32
| +0.7% | +$98 | ﹤0.01% | 6898 |
|
|
2022
Q3 | $21K | Sell |
4,602
-459
| -9% | -$3.29K | ﹤0.01% | 7004 |
|
|
2022
Q2 | $30K | Sell |
5,061
-12,877
| -72% | -$66.1K | ﹤0.01% | 7044 |
|
|
2022
Q1 | $117K | Sell |
17,938
-1,480
| -8% | -$14.6K | ﹤0.01% | 6772 |
|
|
2021
Q4 | $249K | Buy |
19,418
+9,164
| +89% | +$128K | ﹤0.01% | 6366 |
|
|
2021
Q3 | $142K | Sell |
10,254
-1,611
| -14% | -$16.9K | ﹤0.01% | 6520 |
|
|
2021
Q2 | $122K | Sell |
11,865
-34,509
| -74% | -$342K | ﹤0.01% | 6407 |
|
|
2021
Q1 | $448K | Buy |
46,374
+24,898
| +116% | +$249K | ﹤0.01% | 5459 |
|
|
2020
Q4 | $154K | Buy |
21,476
+2,452
| +13% | +$16.3K | ﹤0.01% | 5759 |
|
|
2020
Q3 | $90K | Buy |
19,024
+1,533
| +9% | +$7.59K | ﹤0.01% | 5755 |
|
|
2020
Q2 | $98K | Buy |
17,491
+5,601
| +47% | +$23.3K | ﹤0.01% | 5680 |
|
|
2020
Q1 | $43K | Sell |
11,890
-8,535
| -42% | -$57.3K | ﹤0.01% | 5922 |
|
|
2019
Q4 | $173K | Sell |
20,425
-683
| -3% | -$4.93K | ﹤0.01% | 5717 |
|
|
2019
Q3 | $142K | Buy |
21,108
+13,799
| +189% | +$97.9K | ﹤0.01% | 5862 |
|
|
2019
Q2 | $49K | Sell |
7,309
-909
| -11% | -$4.94K | ﹤0.01% | 6309 |
|
|
2019
Q1 | $52K | Buy |
+8,218
| New | +$63.6K | ﹤0.01% | 6177 |
|
|
2018
Q3 | – | Sell |
-6
| Closed | – | – | 7247 |
|
|
2018
Q2 | $0 | Buy |
+6
| New | +$22 | ﹤0.01% | 7066 |
|
|
2017
Q4 | – | Sell |
-1,571
| Closed | -$5K | – | 7011 |
|
|
2017
Q3 | $5K | Buy |
+1,571
| New | +$4.06K | ﹤0.01% | 6718 |
|
|
2017
Q2 | – | Sell |
-3
| Closed | – | – | 6920 |
|
|
2017
Q1 | $0 | Buy |
3
+2
| +200% | +$7 | ﹤0.01% | 6950 |
|
|
2016
Q4 | $0 | Sell |
1
-604
| -100% | -$2.69K | ﹤0.01% | 7012 |
|
|
2016
Q3 | $3K | Buy |
605
+503
| +493% | +$1.63K | ﹤0.01% | 6725 |
|
|
2016
Q2 | $0 | Buy |
102
+2
| +2% | +$3 | ﹤0.01% | 7105 |
|
|
2016
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 6981 |
|
|
2015
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 7283 |
|
|
2015
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 7186 |
|
|
2015
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 7248 |
|
|
2015
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 7033 |
|
|
2014
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 7660 |
|
|
2014
Q3 | $0 | Sell |
100
-333
| -77% | -$1.35K | ﹤0.01% | 7982 |
|
|
2014
Q2 | $2K | Buy |
433
+333
| +333% | +$1.35K | ﹤0.01% | 7814 |
|
|
2014
Q1 | $0 | Sell |
100
-42
| -30% | -$124 | ﹤0.01% | 7760 |
|
|
2013
Q4 | $0 | Buy |
142
+42
| +42% | +$102 | ﹤0.01% | 7862 |
|
|
2013
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 7853 |
|
|
2013
Q2 | $0 | Buy |
+100
| New | +$336 | ﹤0.01% | 7676 |
|
Other funds holding APYX
NCM
ACM
RA
VCM
ACM
SBCM
EIM
HKAM
Bank of America's APYX Position: Q1 2026 in Review
Bank of America sold out of Apyx Medical (APYX) in Q1 2026, closing a stake of 17,687 shares — an estimated $61.9K sold.
Bank of America first reported a position in APYX in Q2 2013 and held it in 46 quarters. The position peaked at $448K in Q1 2021. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.
- Bank of America reported no remaining Apyx Medical position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 17,687 Apyx Medical shares in Q1 2026, an estimated $61.9K.
- Bank of America first reported a position in Apyx Medical in Q2 2013 and held it in 46 quarters.
- Bank of America's Apyx Medical position peaked at $448K in Q1 2021.
- 67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.